STRONGSVILLE, OHIO – Roscoe Medical and Carex Health Brands have merged, creating what company officials anticipate will be a combined company well-positioned to better serve the growing home health care market, “with dominant market distribution across all channels from retail to DME and managed care, with a product portfolio that is second to none.”
“This transaction presents an opportunity to offer even greater combined value to our customers by offering Carex Health Brand products to the DME dealer channel where many dealers are looking to increase their retail (cash) business,” said Paul Guth, president and CEO of Roscoe Medical. “It aligns our goal of providing innovative solutions to our dealers as we continue to invest in the industry.”
“The Roscoe brand has long been admired for many of the same values as Carex including quality, value and integrity,” said Matt McElduff, president of Carex Health Brands. “We are very excited by the opportunities this merger creates, bringing Carex into many new product categories we haven’t been in before. In addition, there is very little channel or product overlap between Roscoe and Carex.”
Roscoe Medical and Carex Health exhibited at last month’s Medtrade Spring in Las Vegas (Carex Booth is pictured on right), and both have committed to space at the upcoming Medtrade, scheduled for Oct 20-23, 2014, in Atlanta. “It is too earlier in the process for us to make the decision if we will exhibit as one company or as separate companies,” says Laura Casto, vice president, Marketing, Roscoe Medical Inc. “We have had some initial discussions about how the synergies to the two companies will benefit HME providers who are searching for ways to remain commercially viable in today’s HME market. We are excited about utilizing Medtrade as a venue to educate providers on how Carex and Roscoe can help them find ways diversify their business and educate them on best practices in the retail space.”
Key strategic benefits of the merger include:
• Expanded product offerings and larger market distribution footprint. The diversified products and larger market distribution footprint of the combined organization will strengthen the company’s ability to serve home healthcare customers across North America.
• Accelerated innovation. The anticipated pooling of the combined organization’s research and technology will help to streamline product development and better address the evolving needs of a continual growing consumer demographic.
• Enhanced financial flexibility and strength. The merger will allow the combined company to pursue growth opportunities while continually investing in the HME industry.
Paul Guth will serve as CEO of the new company and president of Roscoe Medical. Matt McElduff will continue to be president of Carex Health Brands. The combined company’s management team will remain in place.